Announced Mon, 15 Jun · 16:50 IST
Gland Pharma: Independent Director resigns over conflict of interest; board restructured
Management Changes View source PDF
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹2210.00
prior close
₹2218.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.7-0.1+0.3-0.5-0.5-0.6-1.1+3.4+4.7+13.1+15.2——
Up moveDown movePending
AI summary
Gland Pharma's board approved: (1) re-appointment of Udo J. Vetter as Independent Director for a 2nd 5-year term (Jul 2026–Jul 2031); (2) appointment of William Robert Keller, currently on the Wuxi Biologics board, as Additional Independent Director; (3) acceptance of C.S.N. Murthy's resignation as Independent Director due to a potential future conflict of interest, as his own company plans to enter a similar business segment. Board committees were realigned accordingly.
Likely market impact
Proactive governance move with smooth board transition. New director brings 40+ years of pharma experience across Asia markets.